X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - HEALTHTECHZONE.COM - Healthcare Providers - 13/Aug 13:11

Otsuka Precision Health and Click Therapeutics Announce Launch of Rejoyn™, the First-And-Only Prescription Digital Therapeutic Cleared by the FDA for the Adjunctive Treatment of Major Depressive Disorder (MDD) Symptoms

Articles similaires

Sorry! Image not available at this time

The Emergence of Digital Therapeutic and Telehealth

itnewsafrica.com - 03/Sep 14:02

The emergence of digital therapeutics has empowered healthcare users to play an active role in their treatment. Digital therapeutics and telehealth...

Sorry! Image not available at this time

Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy

healthtechzone.com - 05/Sep 21:34

Sorry! Image not available at this time

Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy

healthtechzone.com - 05/Sep 21:34

Sorry! Image not available at this time

Travere Therapeutics Announces Full FDA Approval of Filspari (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy

drugs.com - 05/Sep 05:09

SAN DIEGO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the U.S. Food and Drug Administration...

Sorry! Image not available at this time

Travere Therapeutics Announces Full FDA Approval of Filspari (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy

drugs.com - 05/Sep 05:09

SAN DIEGO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the U.S. Food and Drug Administration...

Sorry! Image not available at this time

Semaglutide does not increase risk of depression or suicidal thoughts

news.medical.net - 04/Sep 11:06

Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons...

Sorry! Image not available at this time

Semaglutide does not increase risk of depression or suicidal thoughts

news.medical.net - 04/Sep 11:06

Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons...

Sorry! Image not available at this time

Iron Deficiency Anemia Market Analysis 2034 | Iron Deficiency Anemia Therapies, Clinical trials, Iron Deficiency Anemia prevalence, Treatment Algorithms | Akebia Therapeutics, Shield Therapeutics

mountaintoday.in - 04/Sep 08:17

Iron Deficiency Anemia Market As per DelveInsight, the Iron Deficiency Anemia Market is anticipated to grow immensely in the coming years owing to the...

Sorry! Image not available at this time

Iron Deficiency Anemia Market Analysis 2034 | Iron Deficiency Anemia Therapies, Clinical trials, Iron Deficiency Anemia prevalence, Treatment Algorithms | Akebia Therapeutics, Shield Therapeutics

mountaintoday.in - 04/Sep 08:17

Iron Deficiency Anemia Market As per DelveInsight, the Iron Deficiency Anemia Market is anticipated to grow immensely in the coming years owing to the...

Sorry! Image not available at this time

MindBio advances world-first psychedelic microdosing clinical trials

themarketherald.ca - 29/Aug 14:44

MindBio Therapeutics (CSE:MBIO) announces the successful completion of its Phase 1 and 2a clinical trials on depression treatment.

Les derniers communiqués